⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37827 | 0.75 | — | — | |
| SCHEMBL645473 | 0.73 | — | — | |
| SCHEMBL1491982 | 0.73 | — | — | |
| SCHEMBL2121156 | 0.73 | — | — | |
| SCHEMBL27858218 | 0.73 | — | — | |
| SCHEMBL130181 | 0.73 | — | — | |
| SCHEMBL8960466 | 0.73 | — | — | |
| SCHEMBL8960438 | 0.73 | — | — | |
| SCHEMBL2161000 | 0.71 | — | — | |
| SCHEMBL8960280 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1917239-A1 | FLUOROPROSTAGLANDINS NITRODERIVATIVES | Pfizer, Inc. (US) | 2008-05-07 | — | — | EP | claimed |
| WO-2007000642-A1 | FLUOROPROSTAGLANDINS NITRODERIVATIVES | PFIZER INC. (US) | 2007-01-04 | — | — | WO | claimed |
| EP-0171992-B1 | PHARMACEUTICALS CONTAINING PROSTAGLANDIN I2 | MITSUBISHI KASEI CORPORATION (JP) | 1990-06-06 | — | — | EP | claimed |
| US-4837342-A | STABILITY | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-06-06 | — | — | US | claimed |
| US-4699921-A | CIRCULATION AMELIORATING AND ANTIULCER EFFECT | MITSUBISHI YUKA PHARMACEUTICAL CO., LTD. (JP) | 1987-10-13 | — | — | US | claimed |
| EP-0234576-A1 | Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1987-09-02 | — | — | EP | claimed |
| EP-0171992-A2 | Pharmaceuticals containing prostaglandin I2 | MITSUBISHI KASEI CORPORATION (JP) | 1986-02-19 | — | — | EP | claimed |
| CN-116143757-B | Multifunctional compound, composition and application of degradable BTK kinase | 杭州和正医药有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118302418-A | Aromatic heterocyclic compound and application thereof | 中国科学院上海药物研究所 | 2024-07-05 | — | — | CN | disclosed |
| EP-4393907-A1 | POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION | Neushen Therapeutics (Shanghai) Co., Ltd (CN) | 2024-07-03 | — | — | EP | disclosed |
| CN-118103775-A | Composition for forming resist underlayer film | 日产化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| EP-4365178-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF, AND APPLICATION THEREOF | Shanghai Allist Pharmaceuticals Co., Ltd. (CN) | 2024-05-08 | — | — | EP | disclosed |
| CN-117832494-A | Battery cell | 珠海冠宇电池股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-4699921-A | CIRCULATION AMELIORATING AND ANTIULCER EFFECT | MITSUBISHI YUKA PHARMACEUTICAL CO., LTD. (JP) | 1987-10-13 | — | — | US | disclosed |
| US-4699921-A | CIRCULATION AMELIORATING AND ANTIULCER EFFECT | MITSUBISHI YUKA PHARMACEUTICAL CO., LTD. (JP) | 1987-10-13 | — | — | US | disclosed |
| EP-0236510-A1 | PROSTACYCLINS AND DRUGS CONTAINING THE SAME | MITSUBISHI KASEI CORPORATION (JP) | 1987-09-16 | — | — | EP | disclosed |
| EP-0234576-A1 | Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1987-09-02 | — | — | EP | disclosed |
| EP-0234158-A1 | (2-Chloro-3-oxo-1-alkenyl)bicyclo (3.3.0.) octene derivative and process for preparing the same | MITSUBISHI KASEI CORPORATION (JP) | 1987-09-02 | — | — | EP | disclosed |
| EP-0171992-A2 | Pharmaceuticals containing prostaglandin I2 | MITSUBISHI KASEI CORPORATION (JP) | 1986-02-19 | — | — | EP | disclosed |
| EP-0171992-A2 | Pharmaceuticals containing prostaglandin I2 | MITSUBISHI KASEI CORPORATION (JP) | 1986-02-19 | — | — | EP | disclosed |